Afeyan cautioned against overhyping AI’s ability to cure diseases such as cancer, arguing that scientific progress must be accompanied by greater humility about what researchers understand about human physiology.: इस घटनाक्रम पर आधिकारिक अपडेट दर्ज किया गया है। Noubar Afeyan, co-founder and chairman of Moderna In

बाजार और अर्थव्यवस्था: क्या हुआ बड़ा बदलाव?

Afeyan cautioned against overhyping AI’s ability to cure diseases such as cancer, arguing that scientific progress must be accompanied by greater humility about what researchers understand about human physiology.

Noubar Afeyan, co-founder and chairman of Moderna In

Artificial intelligence (AI) could transform scientific discovery and accelerate drug development, but replacing clinical trials with digital simulations remains a distant prospect given the complexity of human biology, Noubar Afeyan, co

Afeyan cautioned against exaggerated claims about AI’s potential to cure diseases such as cancer, arguing that scientific progress must be accompanied by greater humility about what researchers understand about human physiology.

प्रमुख वित्तीय आंकड़े और कंपनियों का रुख

  • •Afeyan cautioned against overhyping AI’s ability to cure diseases such as cancer, arguing that scientific progress must be accompanied by greater humility about what researchers understand about human physiology.
  • •Noubar Afeyan, co-founder and chairman of Moderna In
  • •Artificial intelligence (AI) could transform scientific discovery and accelerate drug development, but replacing clinical trials with digital simulations remains a distant prospect given the complexity of human biology, Noubar Afeyan, co
  • •Afeyan cautioned against exaggerated claims about AI’s potential to cure diseases such as cancer, arguing that scientific progress must be accompanied by greater humility about what researchers understand about human physiology.

ताजा स्थिति व आगे का अपडेट

विशेषज्ञों और पर्यवेक्षकों के अनुसार इस कदम के महत्वपूर्ण परिणाम सामने आ सकते हैं। आगे की आधिकारिक घोषणाओं की प्रतीक्षा है।